Building Capacity of Burma’s Department of Food and Drug Administration

Jun 2018
U.S. Ambassador’s visit to DFDA national laboratory

Since 2013, PMI has supported the Department of Food and Drug Administration (DFDA) of Burma’s Ministry of Health through investments in expert technical assistance, capacity building of staff, and specialized equipment. PMI support combined with Burma’s strong country ownership and commitment have resulted in great and long-lasting success.

PMI’s investments led to the national drug testing laboratory achieving ISO 17025 accreditation in December 2016, earlier than expected. This accreditation by the American National Accreditation Board (ANAB) makes the DFDA laboratory the first drug testing laboratory in Southeast Asia to earn ANAB certification, and signals the country’s commitment to ensuring accurate drug quality testing. The ISO accreditation helps DFDA provide high-quality testing and surveillance to prevent counterfeit and substandard medicines from threatening the effectiveness of current antimalarial treatments or causing drug resistance. These efforts send a clear signal to the global pharmaceutical market that the country is serious about protecting drug quality.

Ceremony for the achievement of ISO accreditation
Ceremony for the achievement of ISO accreditation
Villagers receive their bednets in rural Laos.
            Athit Chanthalath, USAID
Symposium on topics related to ISO Accreditation

Annual Report

13th Annual Report to Congress
Read the PMI Thirteenth Annual Report [PDF, 11MB]


Find a collection of the most important news, stories from the field, and new resources from the past six months.

Photo of a family in front of an ITN.

View the current issue >>